Reprogramming of B lymphoid cells in human lymphoma pathogenesis

Area of Science:

• Cellular plasticity and differentiation
• Hematopoiesis and lymphoid development
• Cancer biology and pathogenesis

Background:

• Differentiated cells were traditionally considered terminally fixed in their fate.
• Recent studies challenge this notion, demonstrating plasticity in mature cells, including lymphoid cells.
• The implications for normal development and cancer remain largely unexplored.

Purpose of the Study:

• To investigate cellular plasticity in malignant Hodgkin/Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL).
• To elucidate the molecular mechanisms underlying the altered phenotype of cHL cells.
• To explore the relevance of lymphoid cell plasticity in human lymphoma pathogenesis.

Main Methods:

• Analysis of transcription factor networks in HRS cells.
• Investigating the role of E2A antagonists, activated B cell factor 1 (ABF-1) and inhibitor of differentiation 2 (Id2).
• Comparison with data from mouse models of lymphoid cell plasticity.

Main Results:

• Malignant HRS cells exhibit plasticity, similar to observations in mouse models.
• Functional disruption of the transcription factor E2A occurs in HRS cells due to ABF-1 and Id2 overexpression.
• Loss of B cell-specific gene expression and upregulation of B lineage-inappropriate genes are observed.

Conclusions:

• Human lymphoid cells, including malignant ones, possess significant plasticity.
• Altered transcription factor networks, specifically involving E2A, ABF-1, and Id2, explain the unique phenotype of cHL.
• These findings offer insights into the pathogenesis of human lymphoma.